Depression, a prevalent and debilitating disorder, necessitates novel treatments beyond conventional drugs. Stingless bee honey, rich in antioxidants, emerges as a potential antidepressant candidate, explored comprehensively through monoamine, inflammatory, and neurotrophin hypotheses.
This comprehensive review delves into the urgent need for safer and more effective depression treatments, considering the limitations of conventional drugs. The focus is on Stingless Bee Honey (SBH), recognized for its high antioxidant content, and its potential as an antidepressant is explored through the lenses of the monoamine, inflammatory, and neurotrophin hypotheses.
Stingless bee honey's potential as an antidepressant is examined in the context of its antioxidant richness, offering a new avenue for addressing depression beyond conventional drug approaches. The review highlights the importance of exploring alternative medicines, such as SBH, for safer and more efficacious depression treatments.